The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
Background: In breast cancer patients, the administration of Trastuzumab and Doxorubicin is associated with an increased risk of cardiotoxicity. The aim of the study was to determine if the antioxidant probucol would be useful in attenuating this drug induced cardiotoxicity. Methods: In an acute mu...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1993/4252 |